Conference Coverage

Philips Healthcare released Spectral CT 7500, which has regulatory clearance in Europe and from the FDA
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane
Function and Productivity Drive Computed Tomography Trends

The computed tomography (CT) market was valued at $6.7 million in 2020, and it is expected to reach $9.5 million by 2026 ...

Time November 04, 2021
arrow
The theme this year is Redefining Radiology. RSNA 2021 will highlight new ideas and technologies that redefine what it means to work as a radiologist. This theme will be kicked off in the opening session, held in Arie Crown Theater at McCormick Place on Sunday, November 28, at 4 p.m. CT, when Mahoney and James Merlino, M.D., discuss the new ideas and technologies that are redefining what it means to be a radiologist today.
Blog | RSNA | By Melinda Taschetta-Millane
Chicago, Here We Come!

The in-person 2021 Healthcare Information Management Systems Society (HIMSS) meeting in August was the first glimmer of ...

Time November 04, 2021
arrow
The Siemens Naeotom Alpha is the first commercialized photon-counting CT scanner. It gained FDA clearance Sept. 30, 2021. The image shows the system undergoing phantom testing with the outer covers off, showing the motion of the X-ray source and detector ring. Image by Deutscher Zukunftpreis/Ansgar Pudenz.
Feature | Computed Tomography (CT) | By Dave Fornell, ITN Editor
First Photon-counting CT System Cleared by the FDA

The U.S. Food and Drug Administration (FDA) cleared the world's first photon-counting computed tomography (CT) scanner ...

Time November 04, 2021
arrow
MIM Software Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for additional automatically segmented contours and local deployment for Contour ProtégéAI, its robust AI auto-contouring solution
News | Artificial Intelligence
MIM Software Inc. Receives FDA 510(k) Clearance for Additional AI Contours and Local Deployment

November 3, 2021 — MIM Software Inc. announced it has received 510(k) clearance from the U.S. Food and Drug ...

Time November 03, 2021
arrow
the all new Sectra Keypad—designed in close collaboration with breast radiologists, it empowers users to be more efficient during mammography screening reading and beyond. Its ergonomic design reduces fatigue while easily reconfigurable keys provide access to the right tools at the right time
News | Enterprise Imaging
Sectra to Highlight Brilliant Radiology Workflows at RSNA 2021

November 3, 2021 — “Brilliant workflows. Made for you.” is the key theme for international medical imaging IT and ...

Time November 03, 2021
arrow
The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura Dawson, MD, FASTRO, Chair of the ASTRO Board of Directors, in response to the 2022 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules announced by the Centers for Medicare and Medicaid Services (CMS)
News | Radiation Oncology
ASTRO Deeply Concerned and Disappointed Over CMS 2022 Final Rules

November 3, 2021 — The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura ...

Time November 03, 2021
arrow
PaxeraHealth has announced that it will be unveiling the Ark - a patent pending technology - at RSNA 2021. Inspired by the story of Noah’s Ark, the Ark is a zero-coding authoring platform that offers "Algorithms as a service" to help healthcare systems and academic centers to DIY their own artificial intelligence (AI) algorithms for all possible modalities, body parts, and anomalies.
News | Artificial Intelligence
PaxeraHealth Launches the Ark at RSNA 2021

November 2, 2021 — PaxeraHealth has announced that it will be unveiling the Ark - a patent pending technology - at RSNA ...

Time November 02, 2021
arrow
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.
Feature | Radiology Business | Melinda Taschetta-Millane
Top 10: Most Popular Radiology Technology Content in October 2021

November 2, 2021 — Here is a list of the Top 10 most popular pieces of content on ITNonline.com from the month of ...

Time November 02, 2021
arrow
FLASH therapy, powered by the use of Varian’s ProBeam, is an experimental treatment modality delivering radiation therapy at ultra-high dose rates, in typically less than one second.
News | Proton Therapy
Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01

November 2, 2021 — Varian, a Siemens Healthineers company, and the Cincinnati Children's/UC Health Proton Therapy Center ...

Time November 02, 2021
arrow
Philips will demonstrate its Multimodality RT Simulation Workspace, a precision medicine application that provides a vendor-agnostic single space for simulation, multimodality image fusion and contouring
News | ASTRO
Philips Highlights New Patient-centered Innovations at ASTRO 2021

November 2, 2021 — Philips announced new innovations that can help improve cancer care across the patient journey at the ...

Time November 02, 2021
arrow
Data presented demonstrates use of DCISionRT and its response subtype (Rst) was able to identify women with ductal carcinoma in situ (DCIS)  (Stage 0 breast cancer) who remain at an elevated risk of recurrence despite receiving breast conserving surgery (BCS) and radiation therapy (RT).
News | Radiation Therapy
PreludeDx Presents DCIS Precision Medicine Study Results at ASTRO 2021 Annual Meeting

November 2, 2021 — Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast ...

Time November 02, 2021
arrow
18F-FDG PET in patients with long-COVID syndrome. A and B: Transaxial sections of group averaged, spatially normalized 18F-FDG PET scans in patients with long-COVID syndrome (A) and control patients (B). C: The pattern expression score (PES; *adjusted for age and sex, for illustration purposes) of the previously established COVID-19-related spatial covariance pattern was not significantly different between patients with long-COVID syndrome and control patients. Boxplots (grey), as well as individual values
News | Coronavirus (COVID-19)
Molecular Imaging Suggests Long-COVID Symptoms may be Caused by Fatigue

November 1, 2021 — Long-term cognitive problems after a COVID-19 diagnosis may be a result of fatigue rather than ...

Time November 01, 2021
arrow
News | Stereotactic Body Radiation Therapy (SBRT)
Serial Radiation Therapy is Safe and Effective as Alternative Treatment to Systemic Therapy for Kidney Cancer

October 29, 2021 — In a new single-arm study, researchers at The University of Texas MD Anderson Cancer Center reported ...

Time October 29, 2021
arrow
Elekta Harmony radiation therapy system at ASTRO 2021.
360 Photos | Radiation Therapy
360 Degree View of the Harmony Radiation Therapy System at ASTRO 2021

This is a virtual tour of the New Elekta Harmony radiation therapy system at the American Society of Radiation Oncology ...

Time October 28, 2021
arrow
In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered in five days rather than over the conventional five weeks produced similar benefits and treatment side effects.
News | Radiation Therapy
Optimizing Preoperative Radiation Therapy in High-risk Sarcoma

October 28, 2021 — In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found ...

Time October 28, 2021
arrow
An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides strong evidence for the addition of androgen deprivation therapy (ADT) to definitive radiotherapy (RT) for the treatment of prostate cancer, with the projection that adding ADT to the treatment of 10-15 men would prevent the development of distant metastasis in one man.
News | Prostate Cancer
International Meta-analysis Quantifies Impact of Three Prostate Cancer Therapy Intensification Strategies

October 28, 2021 — An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides ...

Time October 28, 2021
arrow
ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with MRIdian SMART (MR-guided stereotactic adaptive radiation therapy) were presented as part of the Annual Meeting of the American Society for Radiation Oncology (ASTRO), the world's largest radiation oncology society, held October 24-27, 2021 in Chicago.
News | Stereotactic Body Radiation Therapy (SBRT)
New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients

October 28, 2021 — ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer ...

Time October 28, 2021
arrow
Chest radiograph without Auto Lung Nodule Detection (ALND) and chest radiograph with lung nodule marked.
News | Artificial Intelligence
Samsung Receives FDA Clearance for AI Algorithms that Detect Lung Nodules in Chest X-rays

October 28, 2021 — NeuroLogica Corp. announced it has received Food and Drug Administration (FDA) 510(k) clearance for ...

Time October 28, 2021
arrow
Carestream’s AI features are powered by Eclipse—the engine behind the company’s cutting-edge imaging software platforms—that uses proprietary algorithms and AI to amplify the value of the entire imaging chain.
News | Artificial Intelligence
Carestream Showcases Artificial Intelligence Innovation at RSNA 2021

October 27, 2021 — Carestream Health will highlight the imaging and workflow value of artificial intelligence (AI) in ...

Time October 27, 2021
arrow
Prevencio, Inc. presented data demonstrating that its artificial intelligence (AI) driven HART CVE blood test scores strongly correlate with subsequent adverse cardiac events in lung cancer patients undergoing radiation treatment.
News | Treatment Planning
Prevencio and Memorial Sloan Kettering Cancer Center Data Demonstrates Significant Correlation of AI-driven HART CVE Blood Test Scores with Development of Adverse Heart Events Following Cancer Radiation Treatment

October 27, 2021 — Prevencio, Inc. presented data demonstrating that its artificial intelligence (AI) driven HART CVE ...

Time October 27, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now